Biotie Therapies (Biotie) has appointed Panu Miettinen as chief financial officer (CFO). He will become a member of the group’s management team and will report to Timo Veromaa, president and chief executive officer (CEO). Miettinen will be based at the company’s headquarters in Turku, Finland. Zack McNealy, current interim CFO, will resume his prior duties as vice president, finance and administration at the group’s US subsidiary.
Miettinen, a Finnish native, has expertise in finance, strategy, investor relations, and merger and acquisitions (M&A). Previously he was the CFO of Elektrobit. Before joining Elektrobit, Miettinen was a management consultant at Accenture and KPMG Consulting. Miettinen holds an MSc (Economics) degree from Helsinki School of Economics, Finland.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.